These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 509808)

  • 1. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 3. Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function.
    Drayer DE; Lowenthal DT; Woosley RL; Nies AS; Schwartz A; Reidenberg MM
    Clin Pharmacol Ther; 1977 Jul; 22(1):63-9. PubMed ID: 872496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case.
    Kroboth PD; Mitchum K; Puschett JB
    Am J Kidney Dis; 1984 Jul; 4(1):78-9. PubMed ID: 6204527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P; Laursen HB; Christiansen BD; Moller J
    Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R; Torsti P; Sothmann A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
    Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R
    Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 9. Immediate-release and sustained-release procainamide: bioavailability at steady state in cardiac patients.
    Vlasses PH; Rocci ML; Porrini KA; Greenspon AJ; Ferguson RK
    Ann Intern Med; 1983 May; 98(5 Pt 1):613-4. PubMed ID: 6189438
    [No Abstract]   [Full Text] [Related]  

  • 10. Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.
    Raja R; Kramer M; Alvis R; Goldstein S; DeLosAngeles A
    Trans Am Soc Artif Intern Organs; 1984; 30():18-20. PubMed ID: 6085435
    [No Abstract]   [Full Text] [Related]  

  • 11. The quantitative disposition of procainamide and N-acetylprocainamide in the rat.
    Schneck DW; Grove K; Dewitt FO; Shiroff RA; Hayes AH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):219-25. PubMed ID: 619132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of procainamide in anuric patients undergoing chronic hemodialysis.
    Goicoechea FJ; Bischel MD; Jelliffe RW
    Proc Clin Dial Transplant Forum; 1973; 3():92-5. PubMed ID: 4806653
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interaction of phenytoin with propranolol, procainamide and digoxin].
    Halawa B
    Pol Tyg Lek; 1985 Jul; 40(28):790-3. PubMed ID: 4059101
    [No Abstract]   [Full Text] [Related]  

  • 14. Ventricular ectopy.
    Grauer K; Lopez LM; Curry RW; Kravitz L; Robinson JD; Sands CR
    J Fam Pract; 1984 Dec; 19(6):731-3, 737, 741-2 passim. PubMed ID: 6209358
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
    Kalin ML; Babich MF; Klinke WP; Hui WK
    Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic of procainamide in man.
    Koch-Weser J
    Ann N Y Acad Sci; 1971 Jul; 179():370-82. PubMed ID: 5285382
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
    [No Abstract]   [Full Text] [Related]  

  • 18. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
    Anderson JL
    Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects and pharmacokinetics of mexiletine in ventricular arrhythmia in maintenance hemodialysis patients].
    Kuno T; Takahashi S; Hibiya K; Shimada A; Nagura Y; Takeuchi M; Hatano M
    Nihon Jinzo Gakkai Shi; 1987 Aug; 29(8):1087-92. PubMed ID: 3694885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of blood tests in procaine amide use (apropos of 188 tests in 36 patients)].
    Chiche P; Benaim R; Lellouch A; Godard JP
    Arch Mal Coeur Vaiss; 1972 Jul; 65(7):797-803. PubMed ID: 4633517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.